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Résumé en
anglais
OBJECTIVE: Dominant mutations of the X-linked filamin A () gene are responsible for
filaminopathies A, which are rare disorders including brain periventricular nodular
heterotopia, congenital intestinal pseudo-obstruction, cardiac valves or skeleton
malformations, and often macrothrombocytopenia.
APPROACH AND RESULTS: We studied a male patient with periventricular nodular
heterotopia and congenital intestinal pseudo-obstruction, his unique X-linked allele
carrying a stop codon mutation resulting in a 100-amino acid-long FLNa C-terminal
extension (NP_001447.2: ). Platelet counts were normal, with few enlarged platelets.
FLNa was detectable in all platelets but at 30% of control levels. Surprisingly, all
platelet functions were significantly upregulated, including platelet aggregation and
secretion, as induced by ADP, collagen, or von Willebrand factor in the presence of
ristocetin, as well as thrombus formation in blood flow on a collagen or on a von
Willebrand factor matrix. Most importantly, patient platelets stimulated with ADP
exhibited a marked increase in αβ integrin activation and a parallel increase in talin
recruitment to β, contrasting with normal Rap1 activation. These results are
consistent with the mutant FLNa affecting the last step of αβ activation.
Overexpression of mutant FLNa in the HEL megakaryocytic cell line correlated with
an increase (compared with wild-type FLNa) in PMA-induced fibrinogen binding to
and in talin and kindlin-3 recruitment by αβ.
CONCLUSIONS: Altogether, our results are consistent with a less binding of mutant
FLNa to β and the facilitated recruitment of talin by β on platelet stimulation,
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